JOGO Health

A breakthrough treatment for chronic pain & neuromuscular disorders

Print
Claim My Business
Form C
View on Wefunder
Categories
Technology, Financial Services, Service Businesses
Min Investment
$250
Location
Bridgewater, NJ
Expected Close Date
April 30, 2025
Target Raise
$500.00K-$3.00M
Security Price
$1.13
Website
jogohealth.com
Number of Employees
50
Cash
$2,447,570
Revenue
$274,267
Short Term Debt
$296,795
Cost of Goods
$0
Long Term Debt
$100,157
Net Income
$-2,529,678

Key Deal Facts

25,000+ patients treated across 50+ hospital channel partners
100,000+ patient sessions
Reimbursed by Medicare and commercial insurances
Backed by #1 Hospital in the World - Mayo Clinic, investor & co-development partner
Led by executives from IQVIA, AT&T, Johnson & Johnson, and Astrazeneca
20+ neuromuscular conditions (stroke, migraine, chronic pain, incontinence)
Co-founder with prior AI healthcare exit to #1 clinical research company IQVIA (10X return to invest
Patent protected with 18 claims

Management Team / Advisory Board Bios

Tier 1 VC-Backed
Raised $250K or more from a top-tier venture firm, Repeat Founder
Founder has started a previous company funded with $2M+, Dr. Gordon SilvermanEmeritus Product VisionaryEMG-BF pioneer. Inventor of E-ZPass. Built 1st iteration of JOGO with IBM. Author of foundational textbook “Cognitive Science”. 8 patents. Columbia University Engineering BS, BA, & MS. Polytechnic University Ph.D., Siva Nadarajah Co-Founder and PresidentHealthcare innovation exec. Built company from 0 to exit to IQVIA ($47B clinical research company). Part of the team that took IQVIA (formerly IMS Health) public. 3 healthcare AI patents. Electrical & Electronics Engineering BS., Sanjai Murali Founder and CEOClinical product visionary. Built card-based cash transaction system at AT&T, serving as the foundation of smart chips in credit and ATM cards globally. Built JOGO from 0 to FDA market authorization. Electrical Engineering BS. Computer Engineering MS., Gary Krasilovsky Chief Scientific OfficerPhysical therapy trailblazer. 40+ years in differential diagnosis & treatment in neurological rehabilitation. Educator of 1000+ physical therapy leaders at NYU, Ithaca College, & Hunter College. NYU Physical Therapy - Pathokinesiology MA & PhD., Jason KernenNational Sales DirectorAward-winning sales executive. Former Division Sales Manager at Astrazeneca. Ex-Account Manager at Johnson & Johnson & Jazz Pharmaceuticals. University of Delaware BA. Healthcare Administration MBA., Emily Cassata DPTClinical Program ManagerClinical healthcare pro. Develops products to streamline clinical operations & enhance patient experiences for telehealth & digital rehabilitation. Managed team of 40+ at VC-backed healthcare startup. Ex-Pfizer. Health Sciences BA. Physical Therapy DPT.
Amount Raised : $8,234,396
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment